{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:11:56Z","timestamp":1761174716905,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1046\/j.1469-0691.2003.00582.x","type":"journal-article","created":{"date-parts":[[2003,7,28]],"date-time":"2003-07-28T10:10:07Z","timestamp":1059387007000},"page":"605-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma secretory leukocyte protease inhibitor in febrile patients; An indicator of the presence and extent of pulmonary infection"],"prefix":"10.1016","volume":"9","author":[{"given":"L.A.","family":"Duits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Tjabringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.M.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"van't Wout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Nibbering and","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"van Dissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00582.x_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-125-8-199610150-00009","article-title":"Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)","volume":"125","author":"Bone","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/jcm.33.5.1278-1282.1995","article-title":"Reappraisal with meta-analysis of bacteremia, endotoxemia and mortality in Gram-negative sepsis","volume":"33","author":"Hurley","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib3","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/iai.61.10.4167-4172.1993","article-title":"Induction of release of tumour necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycan","volume":"61","author":"Timmerman","year":"1993","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib4","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1128\/AAC.42.12.3073","article-title":"Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Quantitative measurements and biological activity","volume":"42","author":"Langevelde","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/520222","article-title":"Prediction of microbial infection and mortality in medical patients with fever, plasma procalcitonin, neutrophilic elastase-al-antitrypsin, and lactoferrin compared with clinical variables","volume":"29","author":"Bossink","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(05)60606-X","article-title":"An anti-inflammatory cytokine profile is associated with mortality in febrile patients admitted to the hospital","volume":"351","author":"Van Dissel","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/00365549209061344","article-title":"Endotoxin, TNF, interleukin-6 and parameters of the cellular immune system in patients with abdominal sepsis","volume":"24","author":"Hamilton","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/00003246-199908000-00039","article-title":"Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?","volume":"27","author":"Opal","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/314839","article-title":"Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock","volume":"180","author":"Cohen","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)81895-4","article-title":"Human \u03b2-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis","volume":"88","author":"Goldman","year":"1997","journal-title":"Cell"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib11","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/iai.64.11.4520-4524.1996","article-title":"Antimicrobial activity of antileukoprotease","volume":"64","author":"Hiemstra","year":"1996","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1086\/514098","article-title":"Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi","volume":"176","author":"Tomee","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","article-title":"Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro","volume":"96","author":"McNeely","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4613-1057-0_15","article-title":"Functional studies of human secretory leukocyte protease inhibitor","volume":"240","author":"Ohlsson","year":"1988","journal-title":"Adv Exp Med Biol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.2371565","article-title":"Regulation of proteolysis at the neutrophil\u2013substrate interface by secretory leukocyte inhibitor","volume":"249","author":"Rice","year":"1990","journal-title":"Science"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1165\/ajrcmb\/4.1.26","article-title":"Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium","volume":"4","author":"Amitani","year":"1991","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib17","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/S0021-9258(19)70805-9","article-title":"Degranulation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules","volume":"255","author":"Mainardi","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00917512","article-title":"Activated human peripheral blood neutrophils produce epithelial injury and fibronectin breakdown in vitro","volume":"16","author":"Brown","year":"1992","journal-title":"Inflammation"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01269.x","article-title":"Effects of secretory leukocyte protease inhibitor on the production of the anti-inflammatory cytokines IL-10 and transforming growth factor-beta (TGF-\u03b2) by lipopolysaccharide-stimulated macrophages","volume":"121","author":"Sano","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0092-8674(00)81880-2","article-title":"Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide","volume":"88","author":"Jin","year":"1997","journal-title":"Cell"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/thorax.56.1.36","article-title":"Relation between airway inflammation and the frequency of e xacerbations in patients with smoking related COPD","volume":"56","author":"Gompertz","year":"2001","journal-title":"Thorax"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00003246-200005000-00003","article-title":"Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia","volume":"28","author":"Grobmyer","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia, I. etiology and ecology","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1523-1747.1998.00425.x","article-title":"Induction of SLPI (ALP\/HUSI-I) in epidermal keratinocytes","volume":"111","author":"Wingens","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib25","first-page":"L79","article-title":"Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands","volume":"280","author":"Saitoh","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1620\/tjem.182.319","article-title":"Serum secretory leukoprotease inhibitor levels in chronic bronchitis and Sjogren's syndrome","volume":"182","author":"Andoh","year":"1997","journal-title":"Tohoku J Exp Med"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1164\/ajrccm\/146.6.1426","article-title":"Serum secretory leukocyte inhibitor levels to diagnose pneumonia in the eldery","volume":"146","author":"Kida","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.11.6.7946401","article-title":"Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI\/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes","volume":"11","author":"Sallenave","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1046\/j.1469-0691.2003.00582.x_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/37.4.2926127","article-title":"Tissue distribution of antileukoprotease and lysozyme in humans","volume":"37","author":"Franken","year":"1989","journal-title":"J Histochem Cytochem"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14639495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14639495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:18:21Z","timestamp":1761117501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14639495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S1198743X14639495"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00582.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma secretory leukocyte protease inhibitor in febrile patients; An indicator of the presence and extent of pulmonary infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00582.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}